vs
Indivior Pharmaceuticals, Inc.（INDV）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是LiveRamp Holdings, Inc.的1.7倍（$357.0M vs $212.2M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs 18.8%，领先10.1%）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
INDV vs RAMP — 直观对比
营收规模更大
INDV
是对方的1.7倍
$212.2M
净利率更高
INDV
高出10.1%
18.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $212.2M |
| 净利润 | $103.0M | $39.9M |
| 毛利率 | 82.1% | 71.9% |
| 营业利润率 | 22.7% | 18.6% |
| 净利率 | 28.9% | 18.8% |
| 营收同比 | — | 8.6% |
| 净利润同比 | 390.5% | 255.7% |
| 每股收益（稀释后） | $0.79 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVRAMP
| Q4 25 | $357.0M | $212.2M | ||
| Q3 25 | $314.0M | $199.8M | ||
| Q2 25 | $302.0M | $194.8M | ||
| Q1 25 | $266.0M | $188.7M | ||
| Q4 24 | — | $195.4M | ||
| Q3 24 | $307.0M | $185.5M | ||
| Q2 24 | $299.0M | $176.0M | ||
| Q1 24 | — | $171.9M |
净利润INDVRAMP
| Q4 25 | $103.0M | $39.9M | ||
| Q3 25 | $42.0M | $27.4M | ||
| Q2 25 | $18.0M | $7.7M | ||
| Q1 25 | $47.0M | $-6.3M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $22.0M | $1.7M | ||
| Q2 24 | $-97.0M | $-7.5M | ||
| Q1 24 | — | $-5.4M |
毛利率INDVRAMP
| Q4 25 | 82.1% | 71.9% | ||
| Q3 25 | 73.2% | 70.2% | ||
| Q2 25 | 82.8% | 70.1% | ||
| Q1 25 | 83.1% | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | 78.5% | 72.4% | ||
| Q2 24 | 73.6% | 70.6% | ||
| Q1 24 | — | 72.2% |
营业利润率INDVRAMP
| Q4 25 | 22.7% | 18.6% | ||
| Q3 25 | 13.7% | 10.7% | ||
| Q2 25 | 23.8% | 3.7% | ||
| Q1 25 | 24.8% | -6.1% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | 11.4% | 4.0% | ||
| Q2 24 | -39.5% | -3.0% | ||
| Q1 24 | — | -8.3% |
净利率INDVRAMP
| Q4 25 | 28.9% | 18.8% | ||
| Q3 25 | 13.4% | 13.7% | ||
| Q2 25 | 6.0% | 4.0% | ||
| Q1 25 | 17.7% | -3.3% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | 7.2% | 0.9% | ||
| Q2 24 | -32.4% | -4.3% | ||
| Q1 24 | — | -3.1% |
每股收益（稀释后）INDVRAMP
| Q4 25 | $0.79 | $0.62 | ||
| Q3 25 | $0.33 | $0.42 | ||
| Q2 25 | $0.14 | $0.12 | ||
| Q1 25 | $0.38 | $-0.10 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | $0.16 | $0.03 | ||
| Q2 24 | $-0.72 | $-0.11 | ||
| Q1 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-98.0M | $962.3M |
| 总资产 | $1.2B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVRAMP
| Q4 25 | $195.0M | $403.4M | ||
| Q3 25 | $445.0M | $376.9M | ||
| Q2 25 | $510.0M | $371.1M | ||
| Q1 25 | $373.0M | $420.8M | ||
| Q4 24 | — | $384.3M | ||
| Q3 24 | — | $348.4M | ||
| Q2 24 | — | $342.7M | ||
| Q1 24 | — | $368.9M |
股东权益INDVRAMP
| Q4 25 | $-98.0M | $962.3M | ||
| Q3 25 | $-207.0M | $943.8M | ||
| Q2 25 | $-257.0M | $947.8M | ||
| Q1 25 | $-285.0M | $948.9M | ||
| Q4 24 | — | $957.7M | ||
| Q3 24 | $-310.0M | $932.1M | ||
| Q2 24 | $-281.0M | $951.9M | ||
| Q1 24 | — | $949.1M |
总资产INDVRAMP
| Q4 25 | $1.2B | $1.3B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | — |
| 自由现金流率自由现金流/营收 | -68.6% | — |
| 资本支出强度资本支出/营收 | 6.7% | 0.1% |
| 现金转化率经营现金流/净利润 | -2.15× | — |
| 过去12个月自由现金流最近4个季度 | $-93.0M | — |
8季度趋势，按日历期对齐
经营现金流INDVRAMP
| Q4 25 | $-221.0M | — | ||
| Q3 25 | $-39.0M | $57.4M | ||
| Q2 25 | $158.0M | $-15.8M | ||
| Q1 25 | $75.0M | — | ||
| Q4 24 | — | $45.1M | ||
| Q3 24 | $2.0M | $55.6M | ||
| Q2 24 | $88.0M | $-9.3M | ||
| Q1 24 | — | — |
自由现金流INDVRAMP
| Q4 25 | $-245.0M | — | ||
| Q3 25 | $-59.0M | $56.8M | ||
| Q2 25 | $141.0M | $-16.2M | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | — | $44.8M | ||
| Q3 24 | $-5.0M | $55.4M | ||
| Q2 24 | $84.0M | $-9.6M | ||
| Q1 24 | — | — |
自由现金流率INDVRAMP
| Q4 25 | -68.6% | — | ||
| Q3 25 | -18.8% | 28.4% | ||
| Q2 25 | 46.7% | -8.3% | ||
| Q1 25 | 26.3% | — | ||
| Q4 24 | — | 22.9% | ||
| Q3 24 | -1.6% | 29.8% | ||
| Q2 24 | 28.1% | -5.4% | ||
| Q1 24 | — | — |
资本支出强度INDVRAMP
| Q4 25 | 6.7% | 0.1% | ||
| Q3 25 | 6.4% | 0.3% | ||
| Q2 25 | 5.6% | 0.2% | ||
| Q1 25 | 1.9% | 0.2% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 2.3% | 0.1% | ||
| Q2 24 | 1.3% | 0.1% | ||
| Q1 24 | — | 1.0% |
现金转化率INDVRAMP
| Q4 25 | -2.15× | — | ||
| Q3 25 | -0.93× | 2.09× | ||
| Q2 25 | 8.78× | -2.04× | ||
| Q1 25 | 1.60× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | 0.09× | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
RAMP
暂无分部数据
